Warner pharmaceutical factory (688799.SH) issued an announcement. Recently, its wholly-owned subsidiary, Hunan Warner Daphar, received approval from the Hunan Province Drug Administration for the compliance of GMP (good manufacturing practices) for its active pharmaceutical ingredient, Lanthanum Carbonate, which is located in Wangcheng District, Changsha City. The inspection passed, allowing the company to officially produce and sell the mentioned active pharmaceutical ingredient. The sales of this API product did not have a significant impact on the company's recent performance.
Zhītōng finance and economics APP news, Warner pharmaceutical factory (688799.SH) announced that its wholly-owned subsidiary, Hunan Warner Dai Pharmaceutical Co., Ltd., has received the chemical raw materials medicine application approval notice for dimethyl silicone oil issued by the National Medical Products Administration (NMPA) (Notice No. 2024YS00819) and has been published on the registration information announcement platform for active pharmaceutical ingredients, excipients and packaging materials of the Center for Drug Evaluation (CDE) of the NMPA.
Dimethyl silicone oil is a defoaming agent used to improve abdominal symptoms caused by gas in the gastrointestinal tract; to remove foamy mucus in the stomach during gastrointestinal endoscopy; and to expel gas in the intestine during abdominal X-ray examination. The fact that the chiral pharmaceutical company, chemical raw material medicine, dimethyl silicone oil, has obtained the approval notice for its application for listing as a chemical raw material medicine, indicates that the raw material medicine has met the technical standards for drug evaluation stipulated by the country and has been approved for use in domestic formulations. This will further enrich the company's product line and enhance its core competitiveness.